A detailed history of Covestor LTD transactions in Immunovant, Inc. stock. As of the latest transaction made, Covestor LTD holds 2,507 shares of IMVT stock, worth $68,967. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,507
Previous 253 890.91%
Holding current value
$68,967
Previous $8,000 725.0%
% of portfolio
0.04%
Previous 0.01%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$25.1 - $31.61 $56,575 - $71,248
2,254 Added 890.91%
2,507 $66,000
Q1 2024

May 10, 2024

SELL
$30.27 - $43.79 $30 - $43
-1 Reduced 0.39%
253 $8,000
Q4 2023

Feb 09, 2024

BUY
$31.31 - $44.19 $7,670 - $10,826
245 Added 2722.22%
254 $11,000
Q3 2023

Nov 13, 2023

SELL
$18.55 - $39.96 $37 - $79
-2 Reduced 18.18%
9 $0
Q1 2023

May 15, 2023

SELL
$15.27 - $19.72 $45 - $59
-3 Reduced 21.43%
11 $0
Q4 2022

Feb 13, 2023

BUY
$6.59 - $17.75 $92 - $248
14 New
14 $0
Q1 2022

May 13, 2022

SELL
$5.06 - $8.77 $0 - $0
0 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$7.33 - $9.32 $0 - $0
0 New
0 $0

Others Institutions Holding IMVT

About Immunovant, Inc.


  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.